The global market rout may push Indian startups to reconsider IPO plans. This and more in today’s ETtech Morning Dispatch.

This was supposed to be the year for big, buzzy IPOs but, as Business Insider reports, the tariff-fueled stock market upheaval has killed a comeback before it even started.

Bankers are trying to game out when US initial public offerings could potentially recover after the blow dealt by President ...

CBLL's lockup expiration on April 9th could impact share prices. Click here to find out why CBLL stock is a Sell.

Tech companies like Klarna and StubHub were set to make their stock market debuts. Instead, IPOs are the latest victim of ...

T he inauguration of President Donald Trump in late January had dealmakers dreaming of a resurgent IPO and M&A market. Now, ...

As long as IPOs remain stagnant, average Americans have few ways to share in Silicon Valley's wealth, BI's Dakin Campbell ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

Tata Capital is preparing to list on India’s National Stock Exchange in what could be the country’s biggest IPO this year, ...

Chinese biotech firm Duality Biotherapeutics launched an initial public offering (IPO) of up to HK$1.56 billion ($200.7 million) on Monday in Hong Kong, testing investor appetite amid a global stock ...

Founder-led businesses routinely outperform their ASX benchmarks. We spoke to one of the ASX's newest founders on what drives ...